Pathophysiology of Euglycemic DKA in SGLT2 Inhibitors ...

3.6K

Description

Pathophysiology of Euglycemic DKA in SGLT2 Inhibitors

 • Kidney: Glycosuria, Natriuresis, ↑ Ketone bodies reabsorption

 • Pancreas: ↓ Insulin secretion, ↑ Glucagon secretion

 • Adipose tissue: ↑ Lipolysis

 • Liver: ß-oxidation, ↑ Ketogenesis

→ Euglycemic DKA



Dr priti MD @priti899



#Euglycemic #DKA #SGLT2i #Inhibitors #pathophysiology #nephrology

Contributed by

Dr. Gerald Diaz

@GeraldMD

Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG:  https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/

Medical jobs

view all

0 Comments